TaoWeave, Inc.

Name: TaoWeave, Inc. standardized financial statements, quarterly
Creator: Listed

TWAVNasdaqCIK 746210TechnologyFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$522.0k, Q2 FY2026

Operating income−$841.0k, Q2 FY2026

Net income−$3.3m, Q2 FY2026

TaoWeave, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$k	872	944	626	611	578	563	622	592	601	622	707	522
Cost of revenue	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Gross profit	$k	224	289	(3.0)	120	79.0	135	249	228	244	294	470	274
Research and development	$k	5.0	4.0	50.0	65.0	38.0	2.0	3.0	3.0	3.0	2.0	0.0	0.0
Operating income	$k	(925)	(1,276)	(1,184)	(1,018)	(1,072)	(928)	(691)	(683)	(802)	(785)	(559)	(841)
Interest expense	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Income tax	$k	0.0	(11.0)	0.0	9.0	0.0	1.0	7.0	0.0	0.0	(5.0)	0.0	1.0
Net income	$k	(895)	(1,221)	(1,136)	(983)	(1,040)	(884)	(672)	(605)	(2,290)	(2,788)	1,697	(3,290)
Diluted EPS	$ per share	(0.30)	not reported	(0.07)	not reported	not reported	not reported	(0.59)	not reported	not reported	not reported	0.43	not reported
Basic EPS	$ per share	(4.22)	not reported	(2.02)	(1.38)	(11.25)	not reported	(0.59)	(0.38)	(0.74)	not reported	0.43	(0.84)

Balance sheet

Cash and equivalents$735.0k, Q2 FY2026

Shareholders' equity$5.5m, Q2 FY2026

TaoWeave, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	6.3	6.0	4.9	5.9	5.6	5.0	4.3	10.8	3.7	2.3	2.1	0.7
Current assets	$m	7.6	6.9	5.9	6.3	6.0	5.3	4.8	13.1	10.9	8.2	10.0	5.7
Total assets	$m	8.0	6.9	5.9	6.3	6.0	5.3	4.8	13.1	10.9	8.2	10.0	6.8
Current liabilities	$m	1.3	1.4	1.5	1.2	1.3	1.3	1.4	1.8	1.1	1.2	1.3	1.3
Total liabilities	$m	1.3	1.4	1.5	1.3	1.3	1.3	1.4	1.8	1.1	1.2	1.3	1.3
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Short-term borrowings	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	6.7	5.5	4.4	5.1	4.7	4.0	3.4	11.3	9.8	7.0	8.7	5.5

Cash flow

Operating cash flow−$539.0k, Q2 FY2026

Capital expenditure$0, Q4 FY2023

TaoWeave, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$k	(106)	(705)	(630)	(980)	(911)	(885)	(680)	(37.0)	(1,554)	(744)	(650)	(539)
Capital expenditure	$k	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Share repurchases	$k	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)3.91m, Q1 FY2026

TaoWeave, Inc., shares, quarterly
Line item	Unit	Q1 FY20212021-03-31	Q2 FY20212021-06-30	Q3 FY20212021-09-30	Q1 FY20222022-03-31	Q2 FY20222022-06-30	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q1 FY20252025-03-31	Q1 FY20262026-03-31
Diluted shares (weighted)	m shares	17.8	26.6	30.7	2.1	2.1	2.1	2.1	2.5	3.5	17.1	1.2	3.9

Shares outstanding: 3.88m at Aug 5, 2026, from the cover of the 10-Q filed Aug 7, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. Listed shows no prices and gives no investment advice.